Creative Biostructure to Present at AACR Annual Meeting 2024 Creative Biostructure to Present at AACR Annual Meeting 2024 | April 5-10, 2024 | Booth #2953 Learn More > Close

Structural Research of G Protein-coupled Receptors (GPCRs) Class A

G protein-coupled receptors (GPCRs) are integral membrane proteins that play essential roles in cellular signaling and communication. Among the GPCRs, class A receptors are the largest and most extensively studied subgroup, with significant implications in various physiological processes, including neurotransmission, hormone regulation, and immune responses. In recent decades, structural research on class A GPCRs has significantly advanced, shedding light on their activation mechanisms and providing insights into the development of novel therapeutics.

Class A GPCRs are characterized by their seven-transmembrane helices and their activation through G protein coupling. These receptors are of great interest to researchers due to their involvement in a wide range of physiological functions and their potential as drug targets. Early research on GPCRs mainly relied on X-ray crystallography, which led to landmark discoveries, such as the first high-resolution structure of a GPCR, rhodopsin, in 2000.

Over the past two decades, the advent of cryo-electron microscopy (cryo-EM) has revolutionized structural biology, allowing the visualization of GPCRs at near-atomic resolution. The latest cryo-EM structures of GPR119 (a cannabinoid receptor-like class A GPCR) and its interactions with agonists provide significant revelations regarding its activation and signaling mechanisms, thereby contributing to the advancement of innovative therapeutic strategies.

Overall cryo-EM structures of the GPR119-Gs heterotrimer complexes. Figure 1. Overall cryo-EM structures of the GPR119-Gs heterotrimer complexes. (Qian Y, et al., 2022)

Protein Organism Method Resolution PDB Entry ID
Rhodopsin in ligand-free state (opsin) Bos taurus X-ray diffraction 2.65 Å 4J4Q
Rhodopsin in ligand-free state (opsin) Bos taurus X-ray diffraction 2.29 Å 4X1H
Rhodopsin in ligand-free state (opsin) in complex with ArrFL-1 Bos taurus X-ray diffraction 2.75 Å 4PXF
Rhodopsin, N2C/D282C stabilized opsin bound to RS01 (expressed in HEK293S cells) Bos taurus X-ray diffraction 2.36 Å 6FK6
Rhodopsin-Gαi-βγ complex (expressed in HEK293 cells) Bos taurus Cryo-EM single particle analysis 4.38 Å 6QNO
Rhodopsin-Transducin Complex (expressed in Escherichia coli) Bos taurus Cryo-EM single particle analysis 3.90 Å 6OY9
Visual Signaling Complex between Transducin and Phosphodiesterase 6 (expressed in Escherichia coli) Bos taurus Cryo-EM single particle analysis 3.20 Å 7JSN
Rhodopsin (native dimer) in nanodiscs Bos taurus Cryo-EM single particle analysis 4.50 Å 6OFJ
Rhodopsin in complex with rhodopsin kinase (GRK1) (expressed in Spodoptera frugiperda) Bos taurus Cryo-EM single particle analysis 7.00 Å 7MT9
Bovine rhodopsin in Lipidic Cubic Phase (SACLA) Bos taurus X-ray diffraction 1.80 Å 7ZBC
Human rhodopsin with bound mouse visual arrestin (expressed in HEK293S cells) Homo sapiens X-ray diffraction 3.30 Å 4ZWJ
Human rhodopsin with bound inhibitory G protein (Gi) (expressed in Sf9 cells) Homo sapiens Cryo-EM single particle analysis 4.50 Å 6CMO
Jumping Spider Rhodopsin-1 bound to 9-cis retinal (expressed in HEK293 cells) Hasarius adansoni X-ray diffraction 2.15 Å 6I9K
GPR17-Gi complex (expressed in Spodoptera frugiperda) Homo sapiens Cryo-EM single particle analysis 3.02 Å 7Y89
Gi bound orphan GPR20 in ligand-free state (expressed in Spodoptera frugiperda) Homo sapiens Cryo-EM single particle analysis 3.14 Å 8HS3
GPR21-Gs complex (expressed in Spodoptera frugiperda) Homo sapiens Cryo-EM single particle analysis 2.91 Å 8HMV
GPR52 ligand free form with flavodoxin fusion (expressed in Spodoptera frugiperda) Homo sapiens X-ray diffraction 2.90 Å 6LI1
Orphan GPR88 class A receptor - Gi1 complex, apo form (expressed in Spodoptera frugiperda) Homo sapiens Cryo-EM single particle analysis 3.00 Å 7WZ4
GPR119-Gs-LPC complex (expressed in Trichoplusia ni) Homo sapiens Cryo-EM single particle analysis 3.10 Å 7XZ5
GPR119-Gs Complex with small molecule agonist AR231453 (expressed in Trichoplusia ni) Homo sapiens Cryo-EM single particle analysis 2.87 Å 7WCN
Orphan GPCR in complex with Gi (expressed in Spodoptera frugiperda) Homo sapiens Cryo-EM single particle analysis 3.20 Å 7VUG
LPS-bound GPR174 in complex with Gs protein (expressed in Spodoptera frugiperda) Homo sapiens Cryo-EM single particle analysis 2.76 Å 7XV3
GSK682753A-bound EBI2/GPR183 (expressed in Spodoptera frugiperda) Homo sapiens Cryo-EM single particle analysis 2.98 Å 7TUY
OX1 orexin receptor with bound suvorexant (expressed in Spodoptera frugiperda) Homo sapiens X-ray diffraction 2.75 Å 4ZJ8
Orexin-1 receptor in complex with suvorexant (expressed in Spodoptera frugiperda) Homo sapiens X-ray diffraction 2.26 Å 6TO7
OX1 orexin receptor with bound subtype-selective antagonist (expressed in Spodoptera frugiperda) Homo sapiens X-ray diffraction 3.50 Å 6V9S
OX2 orexin receptor with bound suvorexant (expressed in Spodoptera frugiperda) Homo sapiens X-ray diffraction 2.50 Å 4S0V
OX2 orexin receptor in complex with suvorexant (expressed in Spodoptera frugiperda) Homo sapiens X-ray diffraction 2.74 Å 6TPJ
OX2 orexin receptor with bound antagonist EMPA (expressed in Sf9 cells) Homo sapiens X-ray diffraction 1.96 Å 5WQC
OX2 orexin receptor in complex with G protein and natural peptide-agonist Orexin B (OxB) (expressed in Trichoplusia ni) Homo sapiens Cryo-EM single particle analysis 3.20 Å 7L1U
OX2 orexin receptor in complex with Gi protein and TAK-925 (expressed in Spodoptera frugiperda) Homo sapiens Cryo-EM single particle analysis 3.17 Å 7SQO
OX2 orexin receptor with bound lemborexant (expressed in Spodoptera frugiperda) Homo sapiens X-ray diffraction 2.89 Å 7XRR
C5a anaphylatoxin chemotactic receptor 1 (C5aR) in complex with NDT9513727 (expressed in Spodoptera frugiperda) Homo sapiens X-ray diffraction 2.70 Å 5O9H
C5a anaphylatoxin chemotactic receptor 1 (C5aR) in complex with orthosteric antagonist PMX53 and allosteric antagonist NDT9513727 (expressed in Spodoptera frugiperda) Homo sapiens X-ray diffraction 2.90 Å 6C1Q
α1B-adrenergic receptor in complex with inverse agonist (+)-cyclazosin (expressed in Escherichia coli) Homo sapiens X-ray diffraction 2.87 Å 7B6W
alpha2A adrenergic receptor in complex with an antagonist RSC (expressed in Spodoptera frugiperda) Homo sapiens X-ray diffraction 2.70 Å 6KUX
alpha2A adrenergic receptor GoA signaling complex bound to a G protein biased agonist (expressed in Spodoptera frugiperda) Homo sapiens Cryo-EM single particle analysis 3.47 Å 7W6P
alpha2BAR-GoA complex (expressed in Sf9 cells) Homo sapiens Cryo-EM single particle analysis 2.90 Å 6K41
alpha2C adrenergic G protein-coupled receptor (expressed in Spodoptera frugiperda) Homo sapiens X-ray diffraction 2.80 Å 6KUW

Table 1. Structural research of class-A GPCRs.

Creative Biostructure offers comprehensive structural analysis services for class A GPCRs, tailored to meet the specific needs of researchers and pharmaceutical companies. Our multidisciplinary approach combines cryo-electron microscopy (cryo-EM), X-ray crystallography, and computational modeling to provide a holistic understanding of GPCR structures and their interactions with ligands and G proteins.

Researchers and pharmaceutical companies seeking to gain a deeper understanding of GPCRs and harness this knowledge to develop novel therapies are encouraged to collaborate with Creative Biostructure. Our state-of-the-art facilities, experienced team, and track record of successful structural studies make us a reliable partner in advancing the field of GPCR research. Contact us to discover how our cutting-edge capabilities can empower your research and drive you closer to achieving your scientific goals.

References

  1. Chen G, et al. Activation and allosteric regulation of the orphan GPR88-Gi1 signaling complex. Nature Communications. 2022, 13(1): 2375.
  2. Qian Y, et al. Activation and signaling mechanism revealed by GPR119-Gs complex structures. Nature Communications. 2022, 13(1): 7033.
Inquiry